Income Statement Englewood Lab, Inc.

Stocks

A950140

KR8840110108

Personal Products

End-of-day quote Korea S.E. Other stock markets 16/07/2026			5-day change	1st Jan Change
8,040.00 ^KRW	-2.07%		-6.84%	-28.60%

05-11	Englewood Lab, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-03	Cosmecca Korea Co., Ltd. proposed to acquire an additional 16.67% stake in Englewood Lab, Inc. for KRW 43 billion.	CI

a23c.I7u2Bc_WgQ4sJxU_KAc-0ADzMbQvPrQaUA60fTm5Ahc.FtPxboey4ldvYH8Pal5p6HC2QuRLR41WfWzfOVHKWm9gyZtwhp3FTGYUVA

Published financial data: ENGLEWOOD LAB, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	161B	152B	207B	182B	217B
Other Revenues, Total	-	-1K	-	-	-
Total Revenues	161B	152B	207B	182B	217B
Cost of Goods Sold, Total	127B	126B	159B	144B	157B
Gross Profit	34.2B	25.71B	47.65B	38.44B	59.9B
Selling General & Admin Expenses, Total	13.22B	12.39B	16.16B	15.45B	18.49B
Provision for Bad Debts	1.05B	488M	39.32M	1.01B	13.02M
R&D Expenses	2.44B	2.43B	2.22B	2.81B	3.13B
Depreciation & Amortization - (IS)	541M	465M	362M	358M	357M
Amortization of Goodwill and Intangible Assets - (IS)	49.16M	48.12M	20.63M	18.1M	16.82M
Other Operating Expenses	-	-	-	-	519M
Other Operating Expenses, Total	17.3B	15.82B	18.8B	19.64B	22.53B
Operating Income	16.91B	9.88B	28.86B	18.8B	37.37B
Interest Expense, Total	-741M	-977M	-699M	-907M	-1.16B
Interest And Investment Income	7.76M	12.11M	218M	599M	750M
Net Interest Expenses	-733M	-965M	-481M	-307M	-406M
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	1.03B	545M	42.38M	7.23B	-373M
Other Non Operating Income (Expenses)	-32.29M	-234M	-19.2M	17.6M	-877M
EBT, Excl. Unusual Items	17.17B	9.23B	28.4B	25.73B	35.71B
Gain (Loss) On Sale Of Investments	-	-	-	-	397K
Gain (Loss) On Sale Of Assets	-1.7B	-874M	318M	9.9M	33.92M
Asset Writedown	-368M	-	-	-	-
EBT, Incl. Unusual Items	15.1B	8.35B	28.72B	25.74B	35.75B
Income Tax Expense	101M	1.09B	7.97B	6.12B	10.93B
Earnings From Continuing Operations	15B	7.27B	20.74B	19.63B	24.81B
Net Income to Company	15B	7.27B	20.74B	19.63B	24.81B
Net Income - (IS)	15B	7.27B	20.74B	19.63B	24.81B
Net Income to Common Incl Extra Items	15B	7.27B	20.74B	19.63B	24.81B
Net Income to Common Excl. Extra Items	15B	7.27B	20.74B	19.63B	24.81B
Per Share Items
Net EPS - Basic	754.85	365.69	1.04K	987.92	1.25K
Basic EPS - Continuing Operations	754.85	365.69	1.04K	987.92	1.25K
Basic Weighted Average Shares Outstanding	19.87M	19.87M	19.87M	19.87M	19.87M
Net EPS - Diluted	754.85	365.69	1.04K	987.92	1.25K
Diluted EPS - Continuing Operations	754.85	365.69	1.04K	987.92	1.25K
Diluted Weighted Average Shares Outstanding	19.87M	19.87M	19.87M	19.87M	19.87M
Normalized Basic EPS	540.04	290.27	893.32	809.54	1.12K
Normalized Diluted EPS	540.04	290.27	893.32	809.54	1.12K
Dividend Per Share	-	-	-	100	201
Payout Ratio	-	-	-	11.16	8.04
Supplemental Items
EBITDA	21.21B	14.23B	33.25B	23.91B	42.6B
EBITA	17.01B	10.04B	29B	19.06B	37.99B
EBIT	16.91B	9.88B	28.86B	18.8B	37.37B
EBITDAR	21.23B	14.25B	33.27B	23.95B	42.63B
Effective Tax Rate - (Ratio)	0.67	13.02	27.77	23.76	30.58
Normalized Net Income	10.73B	5.77B	17.75B	16.08B	22.32B
Supplemental Operating Expense Items
Advertising Expense	12.05M	54.36M	116M	175M	187M
Selling and Marketing Expenses	5.77B	5.84B	8.44B	6.67B	8.86B
Research And Development Expense From Footnotes	2.44B	2.43B	2.22B	2.81B	3.13B
Net Rental Expense, Total	16.83M	18.64M	20.39M	34.78M	26.36M
Imputed Operating Lease Interest Expense	3.89M	5.46M	5.97M	11.64M	8.66M
Imputed Operating Lease Depreciation	12.94M	13.18M	14.42M	23.13M	17.7M
Maintenance & Repair Expenses, Total	298M	148M	133M	104M	126M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	8.91B	11.13B	11.44B	28.13B	36.07B
Short Term Investments	324M	-	6.45B	7.69B	7.87B
Trading Asset Securities, Total	-	-	-	2.94B	4.88B
Total Cash And Short Term Investments	9.23B	11.13B	17.89B	38.76B	48.82B
Accounts Receivable, Total	35.27B	35.32B	67.48B	61.95B	82.7B
Other Receivables	-	998M	2.34B	1.11B	1.33B
Notes Receivable	-	-	-	-	-
Total Receivables	35.27B	36.32B	69.82B	63.06B	84.02B
Inventory	39.45B	44.27B	41.99B	40.13B	39.72B
Prepaid Expenses	3.24B	659M	634M	867M	778M
Other Current Assets, Total	580M	2.53B	1.16B	3.99B	2.91B
Total Current Assets	87.76B	94.91B	131B	147B	176B
Gross Property Plant And Equipment	55.46B	41.57B	59.54B	74.58B	77.41B
Accumulated Depreciation	-18.02B	-3.12B	-22.84B	-30.27B	-32.96B
Net Property Plant And Equipment	37.44B	38.45B	36.7B	44.31B	44.45B
Long-term Investments	-	163M	167M	191M	195M
Goodwill	151M	162M	164M	187M	183M
Other Intangibles, Total	489M	476M	355M	1.38B	838M
Deferred Tax Assets Long-Term	1.54B	1.06B	4.57B	6.59B	4.83B
Other Long-Term Assets, Total	797M	163M	192M	263M	284M
Total Assets	128B	135B	174B	200B	227B
Liabilities
Accounts Payable, Total	7.95B	9.08B	24.43B	7.38B	8.95B
Accrued Expenses, Total	1.12B	642M	1.09B	829M	1.39B
Short-term Borrowings	7.77B	5.25B	3.58B	18.18B	18.18B
Current Portion of Long-Term Debt	2.12B	12.35B	4.16B	3.65B	646M
Current Portion of Leases	994M	1.03B	1.1B	867M	1.12B
Current Income Taxes Payable	-	-	4.5B	2.77B	3.96B
Other Current Liabilities	7.96B	6.78B	12.51B	10.4B	15.38B
Total Current Liabilities	27.91B	35.13B	51.36B	44.08B	49.63B
Long-Term Debt	15.07B	5.03B	3.38B	2.74B	2.09B
Long-Term Leases	2.29B	1.49B	810M	4.88B	3.97B
Pension & Other Post Retirement Benefits	1.07B	698M	974M	456M	9.46M
Deferred Tax Liability Non Current	894M	-	2.2B	3.68B	6.75B
Other Non Current Liabilities	-	-1K	-	-	-1K
Total Liabilities	47.23B	42.35B	58.72B	55.84B	62.45B
Common Stock, Total	5.89B	6.29B	6.4B	7.3B	7.13B
Additional Paid In Capital	63.09B	67.44B	68.61B	78.22B	76.36B
Retained Earnings	12.32B	20.3B	41.14B	65.87B	87.33B
Comprehensive Income and Other	-345M	-1.01B	-1.24B	-7.5B	-6.23B
Total Common Equity	80.95B	93.03B	115B	144B	165B
Total Equity	80.95B	93.03B	115B	144B	165B
Total Liabilities And Equity	128B	135B	174B	200B	227B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	19.87M	19.87M	19.87M	19.87M	19.87M
ECS Total Common Shares Outstanding	19.87M	19.87M	19.87M	19.87M	19.87M
Book Value / Share	4.07K	4.68K	5.78K	7.24K	8.28K
Tangible Book Value	80.31B	92.39B	114B	142B	164B
Tangible Book Value Per Share	4.04K	4.65K	5.76K	7.16K	8.23K
Total Debt	28.24B	25.15B	13.02B	30.32B	26B
Net Debt	19.01B	14.02B	-4.87B	-8.44B	-22.82B
Debt Equivalent Oper. Leases	135M	149M	163M	278M	211M
Inventories - Raw Materials, Total	34.23B	33.52B	31.79B	33.11B	32.29B
Inventories - Work In Process, Total	3.95B	5.94B	6.41B	6.36B	7.48B
Inventories - Finished Goods, Total	5.5B	8.65B	8.56B	8.01B	7.25B
Inventories - Others	-	-1K	1K	-	-
Land - (BS)	8.81B	9.69B	9.38B	9.94B	9.83B
Buildings, Total	15.76B	16.46B	18.46B	23.32B	22.95B
Machinery, Total	20.26B	7.56B	23.83B	28.65B	32.79B
Accumulated Allowance for Doubtful Accounts (Supple)	926M	1.43B	942M	2.03B	1.57B

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	15B	7.27B	20.74B	19.63B	24.81B
Depreciation & Amortization - CF	4.19B	4.19B	4.24B	4.85B	4.61B
Amortization of Goodwill and Intangible Assets - (CF)	110M	159M	149M	265M	622M
Depreciation & Amortization, Total	4.3B	4.35B	4.39B	5.12B	5.23B
(Gain) Loss From Sale Of Asset	1.76B	858M	-314M	-10.66M	-34.22M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-401K
Asset Writedown & Restructuring Costs	-	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Provision and Write-off of Bad Debts	1.04B	479M	38.84M	1.09B	13.14M
Other Operating Activities, Total	-7.3B	1.07B	6.36B	-4.22B	6.7B
Change In Accounts Receivable	-12.87B	272M	-31.37B	12.32B	-22.84B
Change In Inventories	-1.4B	-1.8B	1.8B	5.12B	-591M
Change In Accounts Payable	-9.06B	61.24M	15.06B	-19.14B	3.74B
Change in Other Net Operating Assets	1.66B	-2.99B	3.93B	-5.98B	5.36B
Cash from Operations	-6.86B	9.56B	20.64B	13.92B	22.39B
Capital Expenditure	-2.37B	-4.1B	-2.58B	-5.37B	-6.71B
Sale of Property, Plant, and Equipment	187M	34.9M	1.33B	16.85M	85.11M
Cash Acquisitions	-	-	-	-	-
Sale (Purchase) of Intangible assets	-111M	-127M	-22.34M	-74.08M	-31.78M
Investment in Marketable and Equity Securities, Total	-3.66M	14.63M	-6.45B	-2.94B	-2.02B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	0	-	-
Other Investing Activities, Total	92.25M	-1K	-27.29M	-65.87M	1.08B
Cash from Investing	-2.2B	-4.18B	-7.75B	-8.43B	-7.59B
Short Term Debt Issued, Total	-	-	1.56B	15.73B	-
Long-Term Debt Issued, Total	11.76B	-	-	-	-
Total Debt Issued	11.76B	-	1.56B	15.73B	-
Short Term Debt Repaid, Total	-	-	-3.21B	-	-
Long-Term Debt Repaid, Total	-4.89B	-3.67B	-11.02B	-2.43B	-4.48B
Total Debt Repaid	-4.89B	-3.67B	-14.23B	-2.43B	-4.48B
Issuance of Common Stock	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-	-	-	-2.19B	-2B
Common & Preferred Stock Dividends Paid	-	-	-	-2.19B	-2B
Other Financing Activities, Total	1K	-	-	1K	-
Cash from Financing	6.87B	-3.67B	-12.67B	11.11B	-6.47B
Foreign Exchange Rate Adjustments	-112M	-104M	-110M	-1.51B	283M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-
Net Change in Cash	-2.31B	1.61B	116M	15.09B	8.61B
Supplemental Items
Cash Interest Paid	1.16B	854M	659M	960M	1.22B
Cash Income Tax Paid (Refund)	2.93B	835M	3.18B	9.49B	5.59B
Levered Free Cash Flow	-16.8B	233M	15.59B	-4.74B	10.05B
Unlevered Free Cash Flow	-16.33B	844M	16.03B	-4.18B	10.77B
Change In Net Working Capital	28.72B	5.45B	3.8B	15.59B	11.08B
Net Debt Issued / Repaid	6.87B	-3.67B	-12.67B	13.3B	-4.48B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	8.92	4.69	11.67	6.29	10.94
Return on Total Capital	10.95	5.43	14.65	7.78	12.8
Return On Equity %	21.18	8.35	19.95	15.17	16.09
Return on Common Equity	21.18	8.35	19.95	15.17	16.09
Margin Analysis
Gross Profit Margin %	21.27	16.97	23.05	21.1	27.63
SG&A Margin	8.22	8.18	7.81	8.48	8.53
EBITDA Margin %	13.19	9.39	16.08	13.12	19.65
EBITA Margin %	10.58	6.63	14.03	10.46	17.52
EBIT Margin %	10.51	6.52	13.95	10.31	17.24
Income From Continuing Operations Margin %	9.33	4.8	10.03	10.77	11.45
Net Income Margin %	9.33	4.8	10.03	10.77	11.45
Net Avail. For Common Margin %	9.33	4.8	10.03	10.77	11.45
Normalized Net Income Margin	6.67	3.81	8.58	8.83	10.3
Levered Free Cash Flow Margin	-10.44	0.15	7.54	-2.6	4.64
Unlevered Free Cash Flow Margin	-10.16	0.56	7.75	-2.29	4.97
Asset Turnover
Asset Turnover	1.36	1.15	1.34	0.98	1.02
Fixed Assets Turnover	4.22	3.99	5.5	4.5	4.88
Receivables Turnover (Average Receivables)	5.63	4.29	4.02	2.82	3
Inventory Turnover (Average Inventory)	3.48	3.01	3.69	3.5	3.93
Short Term Liquidity
Current Ratio	3.14	2.7	2.56	3.33	3.55
Quick Ratio	1.59	1.35	1.71	2.31	2.68
Operating Cash Flow to Current Liabilities	-0.25	0.27	0.4	0.32	0.45
Days Sales Outstanding (Average Receivables)	64.82	85.02	90.73	129.98	121.77
Days Outstanding Inventory (Average Inventory)	104.84	121.45	98.93	104.52	92.88
Average Days Payable Outstanding	33	23.79	38.98	41.01	19.05
Cash Conversion Cycle (Average Days)	136.66	182.68	150.68	193.49	195.6
Long Term Solvency
Total Debt/Equity	34.89	27.04	11.33	21.07	15.8
Total Debt / Total Capital	25.86	21.28	10.18	17.4	13.64
LT Debt/Equity	21.44	7.01	3.65	5.3	3.68
Long-Term Debt / Total Capital	15.89	5.52	3.28	4.37	3.18
Total Liabilities / Total Assets	36.85	31.28	33.82	27.96	27.51
EBIT / Interest Expense	22.81	10.11	41.28	20.73	32.31
EBITDA / Interest Expense	28.62	14.56	47.57	26.37	36.83
(EBITDA - Capex) / Interest Expense	25.42	10.37	43.88	20.44	31.03
Total Debt / EBITDA	1.33	1.77	0.39	1.27	0.61
Net Debt / EBITDA	0.9	0.99	-0.15	-0.35	-0.54
Total Debt / (EBITDA - Capex)	1.5	2.48	0.42	1.64	0.72
Net Debt / (EBITDA - Capex)	1.01	1.38	-0.16	-0.46	-0.64
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	17.24	-5.79	36.48	-11.88	18.97
Gross Profit, 1 Yr. Growth %	37.84	-24.84	85.39	-19.34	55.82
EBITDA, 1 Yr. Growth %	72.33	-32.91	133.65	-28.08	78.16
EBITA, 1 Yr. Growth %	114.7	-40.99	188.88	-34.28	99.31
EBIT, 1 Yr. Growth %	114.82	-41.55	192.01	-34.86	98.82
Earnings From Cont. Operations, 1 Yr. Growth %	386.63	-51.56	185.5	-5.37	26.42
Net Income, 1 Yr. Growth %	386.63	-51.56	185.5	-5.37	26.42
Normalized Net Income, 1 Yr. Growth %	180.58	-46.25	207.75	-9.38	38.77
Diluted EPS Before Extra, 1 Yr. Growth %	386.63	-51.56	185.5	-5.37	26.42
Accounts Receivable, 1 Yr. Growth %	61.36	0.16	91.04	-8.19	33.49
Inventory, 1 Yr. Growth %	18.52	12.21	-5.13	-4.45	-1.01
Net Property, Plant and Equip., 1 Yr. Growth %	-3.6	2.69	-4.55	20.75	0.32
Total Assets, 1 Yr. Growth %	17.9	5.61	28.26	15.03	13.67
Tangible Book Value, 1 Yr. Growth %	33.04	15.04	23.82	24.42	14.92
Common Equity, 1 Yr. Growth %	33.44	14.92	23.53	25.22	14.38
Cash From Operations, 1 Yr. Growth %	-194.05	-239.29	115.86	-32.55	60.86
Capital Expenditures, 1 Yr. Growth %	-40.47	73.12	-37.05	108.19	24.91
Levered Free Cash Flow, 1 Yr. Growth %	-408.98	-101.36	6.58K	-130.41	-311.91
Unlevered Free Cash Flow, 1 Yr. Growth %	-370.14	-105.07	1.8K	-126.05	-357.99
Dividend Per Share, 1 Yr. Growth %	-	-	-	-	101
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	9.83	5.1	13.39	9.67	2.39
Gross Profit, 2 Yr. CAGR %	16.04	1.78	18.04	22.29	12.11
EBITDA, 2 Yr. CAGR %	37.09	7.53	25.21	29.63	13.19
EBITA, 2 Yr. CAGR %	58.24	12.56	30.56	37.78	14.45
EBIT, 2 Yr. CAGR %	58.3	12.06	30.65	37.91	13.8
Earnings From Cont. Operations, 2 Yr. CAGR %	157.12	53.54	17.6	64.36	9.38
Net Income, 2 Yr. CAGR %	157.12	53.54	17.6	64.36	9.38
Normalized Net Income, 2 Yr. CAGR %	74.16	22.81	28.61	67	12.14
Diluted EPS Before Extra, 2 Yr. CAGR %	157.12	53.54	17.6	64.36	9.38
Accounts Receivable, 2 Yr. CAGR %	20.42	27.13	38.33	32.44	10.71
Inventory, 2 Yr. CAGR %	15.44	15.32	3.17	-4.79	-2.75
Net Property, Plant and Equip., 2 Yr. CAGR %	-7.24	-0.5	-1	7.36	10.06
Total Assets, 2 Yr. CAGR %	5.42	11.59	16.39	21.46	14.35
Tangible Book Value, 2 Yr. CAGR %	14.96	23.71	19.35	24.12	19.57
Common Equity, 2 Yr. CAGR %	15.08	23.83	19.15	24.37	19.68
Cash From Operations, 2 Yr. CAGR %	-24.73	14.46	73.4	20.66	4.16
Capital Expenditures, 2 Yr. CAGR %	-30.46	1.52	4.39	14.48	61.26
Levered Free Cash Flow, 2 Yr. CAGR %	39.85	-79.27	-4.57	350.65	-19.72
Unlevered Free Cash Flow, 2 Yr. CAGR %	33.21	-62.63	-1.9	122.37	-18.02
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	10.63	4.36	14.66	4.25	12.69
Gross Profit, 3 Yr. CAGR %	21.65	0.4	24.3	3.97	32.58
EBITDA, 3 Yr. CAGR %	97.02	8.03	39.27	4.08	44.12
EBITA, 3 Yr. CAGR %	311.18	13.9	54.11	3.86	55.83
EBIT, 3 Yr. CAGR %	292.85	13.57	54.2	3.6	55.8
Earnings From Cont. Operations, 3 Yr. CAGR %	36.48	47.4	88.81	9.38	50.6
Net Income, 3 Yr. CAGR %	36.48	47.4	88.81	9.38	50.6
Normalized Net Income, 3 Yr. CAGR %	138.83	17.7	66.81	14.45	57
Diluted EPS Before Extra, 3 Yr. CAGR %	36.48	47.4	88.81	9.38	50.6
Accounts Receivable, 3 Yr. CAGR %	16.97	13.24	45.61	20.66	32.79
Inventory, 3 Yr. CAGR %	7.21	14.35	8.06	0.57	-3.55
Net Property, Plant and Equip., 3 Yr. CAGR %	-6	-4.04	-1.87	5.78	4.96
Total Assets, 3 Yr. CAGR %	6.95	5.48	16.89	15.93	18.81
Tangible Book Value, 3 Yr. CAGR %	12.49	14.99	23.75	21.02	20.97
Common Equity, 3 Yr. CAGR %	12.6	15.03	23.73	21.14	20.95
Cash From Operations, 3 Yr. CAGR %	-9.85	-7.59	41.41	26.58	32.8
Capital Expenditures, 3 Yr. CAGR %	-43.61	-5.76	-13.43	31.4	17.85
Levered Free Cash Flow, 3 Yr. CAGR %	-10.05	-69.93	42.08	-34.82	250.44
Unlevered Free Cash Flow, 3 Yr. CAGR %	-10.26	-54.9	38.4	-36.95	133.66
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	15.22	11.7	11.73	6.45	9.59
Gross Profit, 5 Yr. CAGR %	11.55	16.18	20.19	8.64	19.27
EBITDA, 5 Yr. CAGR %	22.11	14.7	64.34	16.2	28.19
EBITA, 5 Yr. CAGR %	19.35	2.51	159.86	22.91	36.81
EBIT, 5 Yr. CAGR %	19.2	2.18	152.92	22.74	36.56
Earnings From Cont. Operations, 5 Yr. CAGR %	121.12	-12.14	28.59	53.97	51.77
Net Income, 5 Yr. CAGR %	121.12	-12.14	28.59	53.97	51.77
Normalized Net Income, 5 Yr. CAGR %	51.45	0.95	86.45	35.38	42.31
Diluted EPS Before Extra, 5 Yr. CAGR %	101.01	-12.48	28.59	53.97	51.77
Accounts Receivable, 5 Yr. CAGR %	23.15	18.22	25.09	20.56	30.49
Inventory, 5 Yr. CAGR %	13.65	16.8	5.58	6.27	3.6
Net Property, Plant and Equip., 5 Yr. CAGR %	34.47	1.81	-4.03	0.37	2.74
Total Assets, 5 Yr. CAGR %	8.7	7.93	10.63	11.61	15.87
Tangible Book Value, 5 Yr. CAGR %	1.43	10.21	15.18	18.56	22.06
Common Equity, 5 Yr. CAGR %	1.59	9.05	15.17	18.68	22.09
Cash From Operations, 5 Yr. CAGR %	14.38	1.26	17.11	2.82	25.14
Capital Expenditures, 5 Yr. CAGR %	-17.42	-16.75	-27.86	1.87	11.03
Levered Free Cash Flow, 5 Yr. CAGR %	11.16	-57.14	-7.54	-11.2	13.07
Unlevered Free Cash Flow, 5 Yr. CAGR %	10.97	-44.46	-6.64	-14.62	12.24